Alumni News

After graduating from UW-Madison in 2006, she received a two-year post-doctoral fellowship from the Hope Street Kids Foundation. She served as a post-doctoral fellow with Dr. Michael Cleary at the Department of Pathology at Stanford University.

Holds Patents for: Factor VIII compositions and methods of making and using same. and Factor VIII complex with XTEN and von Willebrand factor protein, And Uses Thereof.

Recent Positions:

Senior Manager, Global Medical Affairs at Biogen Idec (October 2013-2015)
Today, Biogen Idec is the oldest independent biotechnology company in the world. Patients worldwide benefit every day from its industry leading multiple sclerosis (MS) products. The company’s R&D efforts are focused on bringing new therapies to market for patients with neurodegenerative diseases, autoimmune disorders and hemophilia.

Biogen Idec is currently in the pre-approval setting of two breakthrough hemophilia products. The Global Medical Affairs team is supporting the launch of the products world-wide.

Functioning as the main bridge to affiliate Hemophilia Medical Affairs groups to develop and align global strategies.

Support affiliate launches of Alprolix and Eloctate via linking local needs to the Global team.

Responsible for the development of KOL (MD and nursing), Advocacy, and Congress Strategies in collaboration with the local affiliates.